84 results
8-K
CERE
Cerevel Therapeutics Holdings Inc
16 Feb 24
Submission of Matters to a Vote of Security Holders
4:46pm
a request for additional information and documentary materials (the “Second Request”) from the Federal Trade Commission (the “FTC”) in connection
DEFA14A
CERE
Cerevel Therapeutics Holdings Inc
9 Feb 24
Additional proxy soliciting materials
9:00am
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
SUPPLEMENT TO DEFINITIVE PROXY
DEFM14A
CERE
Cerevel Therapeutics Holdings Inc
18 Jan 24
Proxy related to merger
7:44am
Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
CEREVEL THERAPEUTICS
PRER14A
902iw3ndmw6pxa bz
18 Jan 24
Preliminary revised proxy
7:19am
PREM14A
vlnfcs t8eq
5 Jan 24
Preliminary proxy related to merger
5:13pm
DEFA14A
swnv6atq kyj
7 Dec 23
Additional proxy soliciting materials
8:02am
8-K
EX-99.2
buqmu38maidh59gd00
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
kof 2gg4jk8h
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
EX-2.1
jflq5s y32q82p
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
EX-99.1
pfytfcjg2qg
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
EX-1.1
o0xv vacd
12 Oct 23
Cerevel Therapeutics Announces Proposed Public Offering of Common Stock
4:19pm
DEFA14A
dr8iqlm ieic
28 Apr 23
Additional proxy soliciting materials
4:20pm